Vaxdyn Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $12.8M

  • Investors
  • 10

Vaxdyn General Information

Description

Developer of innovative immunotherapies and vaccines intended to prevent infectious diseases. The company's vaccines use antigens, immunomodulators, nanoparticles, and monoclonal antibodies to fight bacterial infections, enabling doctors to reduce the impact of infections caused by drug-resistant pathogens on public health.

Contact Information

Website
www.vaxdyn.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Parque Ciudad del Conocimiento. calle Manuel Manaute Humanes s/n.
  • Edificio central, despacho 6
  • 41704 Dos Hermanas
  • Spain
+34 606
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Parque Ciudad del Conocimiento. calle Manuel Manaute Humanes s/n.
  • Edificio central, despacho 6
  • 41704 Dos Hermanas
  • Spain
+34 606

Vaxdyn Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaxdyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 07-Sep-2026 $12.8M Completed Pre-Clinical Trials
5. Grant 13-Mar-2024 Completed Pre-Clinical Trials
4. Seed Round 08-Mar-2021 Completed Pre-Clinical Trials
3. Grant 07-Jul-2020 Completed Pre-Clinical Trials
2. Secondary Transaction - Private $1.2M Completed Startup
1. Seed Round 01-Jan-2016 $1.2M $1.2M Completed Startup
To view Vaxdyn’s complete valuation and funding history, request access »

Vaxdyn Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Vaxdyn’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vaxdyn Patents

Vaxdyn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3235160-A1 Lipopolysaccharide (lps) deficient acinetobacter baumannii multivalent vaccine Pending 20-Oct-2021
EP-4169529-A1 Lipopolysaccharide (lps) deficient acinetobacter baumannii multivalent vaccine Inactive 20-Oct-2021
EP-4419135-A1 Lipopolysaccharide (lps) deficient acinetobacter baumannii multivalent vaccine Pending 20-Oct-2021
US-20250312434-A1 Lipopolysaccharide (lps) deficient acinetobacter baumannii multivalent vaccine Pending 20-Oct-2021
WO-2023067118-A1 Lipopolysaccharide (lps) deficient acinetobacter baumannii multivalent vaccine. Inactive 20-Oct-2021 A61K39/104
To view Vaxdyn’s complete patent history, request access »

Vaxdyn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaxdyn Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arcano Asesores Financieros Investment Bank Minority
Biovance Capital Partners Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
Arquimea Group Corporation Minority
Bionova Capital Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Vaxdyn FAQs

  • When was Vaxdyn founded?

    Vaxdyn was founded in 2011.

  • Where is Vaxdyn headquartered?

    Vaxdyn is headquartered in Dos Hermanas, Spain.

  • What is the size of Vaxdyn?

    Vaxdyn has 9 total employees.

  • What industry is Vaxdyn in?

    Vaxdyn’s primary industry is Drug Discovery.

  • Is Vaxdyn a private or public company?

    Vaxdyn is a Private company.

  • What is Vaxdyn’s current revenue?

    The current revenue for Vaxdyn is .

  • How much funding has Vaxdyn raised over time?

    Vaxdyn has raised $14.6M.

  • Who are Vaxdyn’s investors?

    Arcano Asesores Financieros, Biovance Capital Partners, European Innovation Council, Arquimea Group, and Bionova Capital are 5 of 10 investors who have invested in Vaxdyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process